Charles River Laboratories International (CRL) Net Cash Flow (2009 - 2025)

Charles River Laboratories International (CRL) has reported Net Cash Flow for 17 consecutive years, with $2.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Net Cash Flow fell 61.39% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at -$8.4 million (up 86.33% YoY), while the FY2025 annual figure was -$8.4 million, up 86.33% from the prior year.
• Net Cash Flow came in at $2.8 million for Q4 2025 at Charles River Laboratories International, down from $27.5 million in the prior quarter.
• The five-year high for Net Cash Flow was $227.0 million in Q1 2021, with the low at -$249.6 million in Q2 2021.
• Average Net Cash Flow over 5 years is -$3.5 million, with a median of $1.4 million recorded in 2023.
• Across the five-year window, Net Cash Flow jumped 311.29% in 2021 and tumbled 314771.43% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at $19.6 million in 2021, then surged by 54.06% to $30.2 million in 2022, then surged by 251.64% to $106.1 million in 2023, then slumped by 93.05% to $7.4 million in 2024, then slumped by 61.39% to $2.8 million in 2025.
• According to Business Quant data, Net Cash Flow over the past three periods registered $2.8 million, $27.5 million, and -$59.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.